World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
34441
World Ranking
18618
National Ranking
9275

Overview

Richard M. Silver is affiliated with the Medical University of South Carolina in the United States. Their research is primarily situated within the field of Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Dermatology, Epidemiology, and Immunology.

The core topics of their work involve systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, inflammatory myopathies and dermatomyositis, dermatologic treatments and research, mast cells and histamine, eosinophilic disorders and syndromes, and autoimmune bullous skin diseases.

Recent papers authored or coauthored by Richard M. Silver include:

  • Systemic sclerosis-associated interstitial lung disease, 2020, The Lancet Respiratory Medicine
  • Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline, 2023, American Journal of Respiratory and Critical Care Medicine
  • Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial, 2020, Annals of the Rheumatic Diseases
  • Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials, 2022, The Lancet Rheumatology
  • Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis, 2022, Arthritis & Rheumatology

Frequent coauthors in their publications include:

  • Ganesh Raghu
  • Virginia Steen
  • Sydney B. Montesi
  • Tanzib Hossain
  • Marya Ghazipura

Richard M. Silver has published frequently in the following venues:

  • Annals of the American Thoracic Society
  • Journal of Scleroderma and Related Disorders
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    O. Kowal-Bielecka;R. Landewé;J. Avouac;S. Chwiesko

  • Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

    Lingyun Sun;Dandan Wang;Jun Liang;Huayong Zhang

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • High resolution computed tomography in early scleroderma lung disease.

    J H Warrick;M Bhalla;S I Schabel;R M Silver

  • Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience.

    Dandan Wang;Huayong Zhang;Jun Liang;Xia Li

  • Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

    Richard M. Silver;K.Scott Miller;Margaret B. Kinsella;Edwin A. Smith

  • Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

    Richard M. Silver;Melvyn P. Heyes;John C. Maize;Bonnie Quearry

  • Systemic sclerosis-associated interstitial lung disease.

    Apostolos Perelas;Richard M Silver;Andrea V Arrossi;Kristin B Highland

  • Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.

    R. M. Silver;J. H. Warrick;M. B. Kinsella;L. S. Staudt

  • Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway.

    Galina S. Bogatkevich;Elena Tourkina;Richard M. Silver;Anna Ludwicka-Bradley

  • A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer

    Leroy Ec;Smith Ea;Kahaleh Mb;Trojanowska M

  • Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Maureen D. Mayes;Lara Bossini-Castillo;Olga Gorlova;José Ezequiel Martin

  • Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma

    Faye N. Hant;Anna Ludwicka-Bradley;He-Jing Wang;Ning Li

  • Interstitial lung disease in systemic sclerosis.

    Predrag Ostojic;Marco Matucci Cerinic;Richard Silver;Kristin Highland

Frequent Co-Authors

Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Virginia D. Steen
Virginia D. Steen Georgetown University
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
John Varga
John Varga University of Michigan–Ann Arbor
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Christopher P. Denton
Christopher P. Denton University College London
Stanley Hoffman
Stanley Hoffman Medical University of South Carolina
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Janet E. Pope
Janet E. Pope University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to mean following the traditional MD route. Today, there are several flexible online degree options and fast-track programs designed for aspiring healthcare professionals with varying backgrounds.

For registered nurses looking to advance, rn to bsn no clinical hours programs offer a convenient way to earn a Bachelor of Science in Nursing without the need for additional on-site clinicals. This can be ideal for working professionals seeking to boost credentials while balancing work responsibilities.

Those aiming for leadership positions or advanced practice roles might consider doctoral degrees. Options like the shortest dnp programs and cheapest dnp programs focus on efficiency and affordability, allowing nurses to achieve a Doctor of Nursing Practice (DNP) credential without a lengthy or costly commitment.

If you’re looking to enter the medical field quickly, fast track medical programs can help you start your career as a Licensed Practical Nurse (LPN) in less time than traditional pathways.

Online options and accelerated programs have opened new doors for prospective healthcare professionals—making it easier than ever to find a pathway that fits your goals and lifestyle.

Best Scientists Citing Richard M. Silver

Trending Scientists